Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo

Detalles Bibliográficos
Autores principales: Xu, Yu-Yin, Chen, Li, Wang, Gui-Lan, Zhou, Jia-Ming, Zhang, Yi-Xin, Wei, Yin-Ze, Zhu, Yuan-Yuan, Qin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326930/
https://www.ncbi.nlm.nih.gov/pubmed/37420163
http://dx.doi.org/10.1186/s12885-023-11135-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326930/
https://www.ncbi.nlm.nih.gov/pubmed/37420163
http://dx.doi.org/10.1186/s12885-023-11135-3

Ejemplares similares